Stockscreener 앱 받기
38.31
2.74%
-1.08
시간 외 거래:
37.76
-0.55
-1.44%
Ascentage Pharma Group International Adr 주식(AAPG)의 최신 뉴스
Ascentage Pharma Completes Offshore Placement to Boost Global Operations - TipRanks
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement - GlobeNewswire Inc.
McGraw Hill, Inc. Plans $500 Million IPO for July 24th (MH) - Defense World
Ascentage Pharma Group International – Unsponsored ADR’s (NASDAQ:AAPG) Lock-Up Period Set To End on July 23rd - Defense World
Gates Industrial (NYSE:GTES) Reaches New 1-Year High After Analyst Upgrade - Defense World
Accelerant Holdings (ARX) to Raise $551 Million in IPO - Defense World
Certara (NASDAQ:CERT) Trading Down 4.8% on Analyst Downgrade - Defense World
Diginex Stock Scheduled to Split on Friday, August 1st (NASDAQ:DGNX) - Defense World
Atalaya Mining (LON:ATYM) Sets New 12-Month High Following Analyst Upgrade - Defense World
Investors Buy Large Volume of Ramaco Resources Call Options (NASDAQ:METC) - Defense World
VerticalScope Holdings Inc. (TSE:FORA) Receives C$10.45 Consensus Price Target from Analysts - Defense World
Ascentage Pharma announces $192.3 million share placement By Investing.com - Investing.com South Africa
Ascentage Pharma announces $192.3 million share placement - Investing.com
Moser Wealth Advisors LLC Lowers Stake in NVIDIA Corporation (NASDAQ:NVDA) - Defense World
Ascentage Pharma Strengthens Leadership with Key Appointments - TipRanks
US Stocks Likely To Open Mixed As Trump Issues Tariff… - inkl
Ascentage Pharma’s Studies to be Featured at 2025 EHA Congress - TipRanks
Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress - marketscreener.com
Ascentage Pharma Unveils Promising Data on Alrizomadlin at ASCO 2025 - TipRanks
Ascentage Pharma Announces Successful AGM Resolutions on May 19, 2025 - TipRanks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV), Xencor (XNCR) and Intellia Therapeutics (NTLA) - The Globe and Mail
Is Ascentage Pharma (AAPG) the Best Performing Healthcare Stock to Buy Now? - Yahoo Finance
Ascentage Pharma Files Annual Report, Announces Shareholder Meeting By Investing.com - Investing.com South Africa
Ascentage Pharma Files Annual Report, Announces Shareholder Meeting - Investing.com
JPMorgan sets Ascentage Pharma stock to Overweight, $27 target - Investing.com
Takeda Pharmaceutical Company (TKPYY) Stock: Strategic Focus on Oncology and Growth Opportunities - Value the Markets
Ascentage Pharma to Announce 2024 Financial Results and Corporate Update - TipRanks
Avoid the Trap: 3 High-yield Dividend Stocks With Safe Payouts - The Globe and Mail
Ascentage Pharma IPO opens flat - Investing.com
Ascentage Pharma shares slide ahead of ADS debut on Nasdaq - Investing.com
Ascentage prices first biotech IPO of 2025, raising $126M - BioPharma Dive
Ascentage Pharma sets terms for $149 million US IPO - The Pharma Letter
Takeda-backed Ascentage Pharma files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha
Market Capitalization: What It Is, Formula for Calculating It - Investopedia
Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares - PR Newswire
Takeda, Ascentage Pharma Sign Option Agreement - Contract Pharma
Top Biotech Stocks: Exploring Innovation Opportunities - MarketBeat
BIIB Stock Quote Price and Forecast - CNN
Capital Markets - Wilson Sonsini
Morningstar | Empowering Investor Success - Morningstar
ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN Logo
4.91%
0.25%
자본화:
|
볼륨(24시간):